Your search for comorbidities returned 91 results

Researchers analyzed data taken from EHR insurance claims of 149,654 patients aged 25 years and older between January 2016 and September 2020.

Using an IV sotalol formulation, researchers were able to develop a safe and cost-effective option for administering the antiarrhythmic drug.

Researchers sought to determine if peripheral artery disease is an independent risk factor for heart failure.

Researchers at AHA 2021 presented a study that examined rates of hypertensive crisis in young cannabis users vs nonusers of different race and sex.

Researchers at AHA 2021 presented a study that sought to determine whether high leptin affects the risk for mortality or morbidity in patients with stable CHD.

A nationwide registry-based study presented at AHA 2021 finds that ticagrelor is associated with a lower risk of bleeding after PCI for ACS.

Researchers at AHA 2021 presented their findings from a study that compared CVD risk factors and in-hospital outcomes in young, Black US adults a decade apart.

Authors performed a systematic review of current evidence for the use of the Atrial Fibrillation Better Care (ABC) pathway and its effect on clinical outcomes.

The researchers’ goal was to determine the clinical impact of stent graft thrombosis and its prognosis.

A large retrospective observational study found large numbers of hospitalized patients with blood pressures exceeding thresholds for hypertension.